---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-001484"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T10:47:22.852746+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab board approves Ethereum-focused treasury strategy, first Nasdaq-listed company to do so

## Summary
- Board approved Ethereum (ETH) as the primary treasury asset; BGLC is first Nasdaq-listed company to do so.
- Cites Ethereum's institutional credibility, staking yield, stablecoin dominance, and upcoming Pectra upgrade.
- Released Ethereum Strategy Whitepaper publicly on company website.
- Company incorporated in Wyoming, which has pro-blockchain regulations; Wyoming Stable Token Act cited.
- CEO Sam Tan says Ethereum treasury strategy enhances financial resilience and attracts forward-thinking investors.

## SEC filing metadata
- accession: 0001477932-25-001484
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001484/0001477932-25-001484-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001484/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-001484
- JSON: https://secwatch.observer/filing/0001477932-25-001484.json
- Plain text: https://secwatch.observer/filing/0001477932-25-001484.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.